Given that dysregulation of the pathways controlled by YAP1 and TEAD family members exerts a significant impact on cancer development and therapeutic resistance [7,18], we decided to explore the impact of our findings in the generation of resistance to trastuzumab in human breast cancer. Here, YAP1 is linked to breast carcinoma.